Anita Lyn Sabichi, MD
Dr. Anita Lyn Sabichi is a medical oncologist who treats lung cancer and malignant pleural mesothelioma patients, as well as those with genitourinary cancers and head and neck cancers, at the Baylor College of Medicine, the Dan L. Duncan Comprehensive Cancer Center, and the Michael E. DeBakey VA Medical Center in Houston, Texas. She works to carry the results of her translational biology and molecular medicine research into patient treatment in order to create the most innovative treatment plans and achieve the best possible outcomes for patients at Baylor.[1]
Education and Career
Dr. Sabichi attended the University of Colorado as an undergraduate, graduating with a Bachelor of Arts degree, and then earned her medical degree at the University of Colorado School of Medicine Anschutz Medical Campus in Denver, Colorado. From there, she went on to complete an internship and residency in Internal Medicine at New York Presbyterian Hospital’s Columbia University campus in New York City and then completed a fellowship in Hematology and Medical Oncology at the National Institutes of Health Clinical Center. She is board-certified in Internal Medicine and Medical Oncology and has been named one of America’s Top Oncologists by the Consumers’ Research Council of America.[1]
Dr. Sabichi serves on the editorial board of The Scientific World Journal and the New Journal of Science. She has personally co-authored 81 publications receiving 4,888 citations.
Research
Dr. Sabichi is actively involved in cancer research. She has contributed to articles on topics including lung cancer and bladder cancer and has co-authored 81 publications receiving 4,888 citations. She is a member of Baylor College of Medicine’s Center for Translational Research on Inflammatory Diseases and was recently awarded an extramural grant:[2]
- Harnessing Allo-immunity to Enhance Immune Checkpoint Inhibitor Responses in Advanced NSCLC, VA-ORD CSR&D, Grant # I01CX002636, 10/01/2023-09/30/2030, Kheradmand F & Sabichi A
Her recent clinical trials include:[3]
- Fenretinide in Treating Patients Who Have Undergone Surgery for Bladder CancerStart of enrollment: 1998 Jul 30. COMPLETED. PHASE 3
- Celecoxib in Treating Patients With Bladder CancerStart of enrollment: 2000 Jun 01. COMPLETED. PHASE 2, PHASE 3
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell CarcinomaStart of enrollment: 2008 Aug 08. ACTIVE, NOT RECRUITING. PHASE 3
Her recent publications include:[3]
- Phase I / II trial of metformin as a chemo-radiosensitizer in a head and neck cancer patient population. Jan O Kemnade, Marcus Florez, Anita Sabichi, Jun Zhang, Pavan Jhaveri, George Chen, Albert Chen, Courtney Miller-Chism, Bulsara Shaun, Susan G Hilsenbeck, David J Hern…>; Oral Oncology. 2023 Oct 1
- Deployment of cisplatin in Veterans with oropharyngeal cancer: toxicity and impact on oncologic outcomes. Ola Soliman, David C Wilde, Jan O Kemnade, Anita L Sabichi, George Chen, Albert Chen, Samantha N Little, Andrew T Huang, David J Hernandez, Vlad C Sandulache>; Laryngoscope Investigative Otolaryngology. 2023 Aug 1
- Persistent ethnicity-associated disparity in anti-tumor effectiveness of immune checkpoint inhibitors despite equal access. Marcus A Florez, Jan O Kemnade, Nan Chen, Wendy Du, Anita L Sabichi, Daniel Y Wang, Quillan Huang, Courtney N Miller-Chism, Aparna Jotwani, Albert C Chen, David Hernan…>; Cancer Research Communications. 2022 Jul 26
Terri Heimann Oppenheimer
WriterTerri Oppenheimer has been writing about mesothelioma and asbestos topics for over ten years. She has a degree in English from the College of William and Mary. Terri’s experience as the head writer of our Mesothelioma.net news blog gives her a wealth of knowledge which she brings to all Mesothelioma.net articles she authors.
Dave Foster
Page EditorDave has been a mesothelioma Patient Advocate for over 10 years. He consistently attends all major national and international mesothelioma meetings. In doing so, he is able to stay on top of the latest treatments, clinical trials, and research results. He also personally meets with mesothelioma patients and their families and connects them with the best medical specialists and legal representatives available.
References
- Baylor College of Medicine. (N.D.). Anita Lyn Sabichi, MD.
Retrieved from: https://www.bcm.edu/people-search/anita-sabichi-29870 - Baylor College of Medicine Research. (N.D.). Center for Translational Research on Inflammatory Diseases Research.
Retrieved from: https://www.bcm.edu/research/research-centers/center-for-translational-research-on-inflammatory-diseases/research - https://www.doximity.com/pub/anita-sabichi-md
Retrieved from: https://www.doximity.com/pub/anita-sabichi-md